Clinical TrialsSearch results
Number of results: 223
Other
- Safety of Biologics in Clinical Use in Japanese Patients with Rheumatoid Arthritis in Long-Term (SECURE)
- Rheumatoid Arthritis
- Japan College of Rheumatology
- 2008-09-01
Other
- Rituximab + standard CHOP (R S-CHOP) vs Rituximab + bi-weekly CHOP (R Bi-CHOP) RCT(phase II/III) low-grade B-cell lymphoma at advanced stage (LowBNHL-RS/BiCHOP-P2/3) (JCOG0203)
- Untreated CD20-positive low-grade B-cell lymphoma at advanced stage
- Japan Clinical Oncology Group(JCOG)
- 2005-07-30
Other
- Research on the usefulness of pneumococcal polysaccharide vaccine for elderly in the nursing home
- Pneumonia in the nursing home
- Research Institute for Microbial Diseases, Osaka University
- 2009-07-17
Other
- Reliability of Implantable Cardioverter-Defibrillator Home Monitoring in Forecasting the Necessity of Regular Office Visit and Patients' Perspectives: Japanese HOME ICD Study
- Tachyarrhythmia and Heart Failure
- Biotronik Japan
- 2009-09-01
Other
- Registration Program for Myelodysplastic Syndromes and Aplastic Anemia
- Myelodysplastic Syndromes Aplastic Anemia
- Keio University School of Medicine
- 2007-04-28
Other
- RCC-SNPs Ensuring-study for Leading Eligibility of patients in Cytokine Therapy
- Renal cell carcinoma
- JISG-KC
- 2007-06-04
Other
- randomized trial for the efficacy of primary prophylaxis with granulocyte colony stimulating factor in advanced childhood mature B-cell malignancies
- advanced childhood mature B-cell malignancies
- Japan Pediatric Leukemia/Lymphoma Study Group
- 2007-04-11
Other
- Randomized study of Taxane vs TS-1 in metastatic or recurrent breast cancer patients
- Metastatic or recurrent breast cancer
- SELECT BC executive committee
- 2006-06-01
Other
- randomized study of Gemicitabine alone or UFT adjuvant chemotherapy for stage IB-IIIA non small cell lung cancer after complete resection
- stage IB-IIIA non small cell lung cancer after complete resection
- West Japan Oncology Group
- 2005-09-06
Other
- Randomized phase III trial of Docetaxel versus docetaxel plus S-1 for second-line treatment of non-small cell lung cancer (NSCLC)
- Advanced non-small cell lung cancer
- The Japan-multinational Trial Organization
- 2009-03-31